Improvement of pharmacokinetics and myeloid effector cell engagement in vivo by Fc-engineering of IgA antibody against the epidermal growth factor receptor
Rösner, T, Kretschmer, A, Lohse, S, Meyer, S, Jansen, J.H.M, Möginger, U, Sondermann, P, Kolarich, D, Leusen, J.H.W, Valerius, T
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
Low-grade inflammation and insulin resistance independently explain substantial parts of the association between body fat and serum C3: The CODAM study
Wlazlo, Nick, van Greevenbroek, Marleen M.J, Ferreira, Isabel, Jansen, Eugene J.H.M, Feskens, Edith J.M, van der Kallen, Carla J.H, Schalkwijk, Casper G, Bravenboer, Bert, Stehouwer, Coen D.A
Published in Metabolism, clinical and experimental (01.12.2012)
Published in Metabolism, clinical and experimental (01.12.2012)
Get full text
Journal Article
440 - Improvement of pharmacokinetics and myeloid effector cell engagement in vivo by Fc-engineering of IgA antibody against the epidermal growth factor receptor
Rösner, T., Kretschmer, A., Lohse, S., Meyer, S., Jansen, J.H.M., Möginger, U., Sondermann, P., Kolarich, D., Leusen, J.H.W., Valerius, T.
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article